In oncology we say one size doesn’t fit all, but if there are any drugs that work in almost all cancers, they have to be platinum drugs especially Cisplatin and Carboplatin. The simplest, effective and cheapest drugs that have no replacement in several cancers are out of stock in most hospitals in India, leaving patients and families to suffer with no treatments even in curable cancers. The global supply chain has been massively impacted, so are the import rates and manufacturing rates. While capping prices of drugs is a welcome move, flexibility that is reviewed dynamically is the need of the hour, a 50% rise in capped price of a 200 rupees drug that is life saving should be accommodated as the cost of lives lost is going to be much more. Request @narendramodi @PMOIndia @JPNadda @MoHFW_INDIA @AmitShahOffice to resolve the situation ASAP

• Platinum chemotherapy shortage in India is becoming a major oncology challenge • Cisplatin & carboplatin are backbone drugs across many cancers • The issue is not just “drug availability” → raw material crisis → pricing pressure → manufacturing economics → supply-chain disruption • Real-world impact: → treatment delays → dose modifications → regimen changes → inventory pressure • Quick visual summary of: ✓ What is happening ✓ Why it is happening ✓ Clinical implications ✓ Possible solutions Would like to hear how different centres are managing this situation. #Oncology #CancerCare #DrugShortage #Cisplatin #Carboplatin #Chemotherapy #OncTwitter #MedTwitter #MVOnco